ESR1 and triple-negative breast carcinoma: Breast cancer is known to be a heterogenous and complex disease, classified based on expression of receptors; estrogen receptors (ER) positive, progesterone receptors (PR) positive, human epidermal growth factor receptor (HER2) amplified breast cancer, or triple negative breast cancer (TNBC) [4,5].